Ito K, Kikuchi S, Yamada M, Torii S, Yoshida M
Department of Pediatrics, Nagoya University School of Medicine.
Arerugi. 1992 Jul;41(7):772-7.
The drug concentrations in nebulizers and nebulized solutions generated by the ultrasonic nebulizer OMRON NE-U10B and the jet nebulizer INSPIRON NEBULIZER 002305 were examined. With the ultrasonic nebulizer, increases in the concentrations of saline, DSCG and isoproterenol in the nebulizer were observed; the concentrations of those in the nebulized solutions also increased. The increase was most dramatic just before the solution was emptied. No degradations of DSCG or isoproterenol were detected in the nebulized solutions, indicating that these drugs are stable against ultrasonic nebulization. An increase in the drug concentrations in the jet nebulizer was also observed. The concentrations of the nebulized solutions also increased, but the concentrations in the nebulized solution were lower than those in the nebulizer at any time. On inhalation therapy, it is important to give consideration to these concentration changes. The nebulizer should not, for example, be refilled with a new drug solution.
对欧姆龙NE-U10B超声雾化器和英普瑞英雾化器002305产生的雾化器及雾化溶液中的药物浓度进行了检测。使用超声雾化器时,观察到雾化器中盐水、色甘酸钠(DSCG)和异丙肾上腺素的浓度增加;雾化溶液中这些药物的浓度也增加。就在溶液排空之前,这种增加最为显著。在雾化溶液中未检测到色甘酸钠或异丙肾上腺素的降解,这表明这些药物对超声雾化稳定。在喷射雾化器中也观察到药物浓度增加。雾化溶液的浓度也增加,但雾化溶液中的浓度在任何时候都低于雾化器中的浓度。在吸入治疗时,考虑这些浓度变化很重要。例如,雾化器不应重新填充新药溶液。